网络药理学联合基因表达数据库芯片分析及分子对接技术探讨健脾清化化瘀汤治疗胃癌前病变的潜在机制
Exploring the potential mechanism of Jianpi Qinghua Huayu Decoction in the treatment of precancerous lesions of gastric cancer based on network pharmacology combined with GEO chip analysis and molecular docking technology
- 北京中医药 2023年42卷第5期 页码：501-507
- 作者机构：
1.北京中医药大学临床医学院，北京 100029
2.首都医科大学附属北京中医医院消化科，北京 100010
- 作者简介：
张亮亮，女，26岁，硕士研究生。研究方向：消化病中医基础及临床研究。
汪红兵，E-mail：wanghongbing@bjzhongyi.com
- 基金信息：国家自然科学基金资助项目(8177150984)
DOI：10.16025/j.1674-1307.2023.05.009
中图分类号：
扫 描 看 全 文
张亮亮，李根，杨帅，等.网络药理学联合基因表达数据库芯片分析及分子对接技术探讨健脾清化化瘀汤治疗胃癌前病变的潜在机制［J］.北京中医药，2023，42（5）：501-507.
ZHANG Liang-liang,LI Gen,YANG Shuai,et al.Exploring the potential mechanism of Jianpi Qinghua Huayu Decoction in the treatment of precancerous lesions of gastric cancer based on network pharmacology combined with GEO chip analysis and molecular docking technology[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(05):501-507.
张亮亮，李根，杨帅，等.网络药理学联合基因表达数据库芯片分析及分子对接技术探讨健脾清化化瘀汤治疗胃癌前病变的潜在机制［J］.北京中医药，2023，42（5）：501-507. DOI： 10.16025/j.1674-1307.2023.05.009.
ZHANG Liang-liang,LI Gen,YANG Shuai,et al.Exploring the potential mechanism of Jianpi Qinghua Huayu Decoction in the treatment of precancerous lesions of gastric cancer based on network pharmacology combined with GEO chip analysis and molecular docking technology[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(05):501-507. DOI： 10.16025/j.1674-1307.2023.05.009.
摘要
目的,2,基于网络药理学联合基因表达数据库（GEO）芯片分析及分子对接技术探讨健脾清化化瘀汤治疗胃癌前病变（PLGC）的成分靶点及信号通路，预测其潜在作用机制。,方法,2,利用中药系统药理学数据库与分析平台（TCMSP）及本草组鉴数据库（HERB）搜集健脾清化化瘀汤中14味药物的活性成分和靶点。通过GEO数据库中的GSE55696基因芯片获取差异表达基因，利用人类孟德尔遗传在线数据库（OMIM）、DisGeNet、GeneCards疾病数据库获取PLGC的相关疾病靶点，运用R软件获取健脾清化化瘀汤治疗PLGC的关键靶点。通过R语言对关键靶点进行基因本体论（GO）和京都基因和基因组的百科全书（KEGG）通路富集分析，利用蛋白互作（STRING）数据库及Cytoscape3.9.1软件绘制关键靶点的蛋白质-蛋白质相互作用（PPI）网络，筛选出核心靶点，利用Cytoscape3.9.1构建健脾清化化瘀汤与PLGC的“活性成分-关键靶点”网络，筛选出核心成分，最后将核心成分与核心靶点进行分子对接，探索蛋白与分子间的亲和性。,结果,2,共获得健脾清化化瘀汤226个活性成分，对应416个药物靶点；获得PLGC差异表达基因1 673个，疾病数据库获得相关靶点1 302个；药物与疾病交集基因149个；GO功能富集分析得到2 802个条目，KEGG通路富集分析得到161条相关通路，主要涉及糖尿病并发症晚期糖基化终末产物/AGEs受体（AGE-RAGE）信号通路与癌症相关信号通路；筛选得到核心活性成分槲皮素、木犀草素等，核心靶点TP53、JUN、AKT1等；分子对接结果证实核心成分与核心靶点之间有较好的结合活性。,结论,2,健脾清化化瘀汤可能通过参与多条信号通路作用于多成分、多靶点，从而发挥治疗PLGC的效用。
Abstract
Objective,2,To investigate the component targets and signaling pathways of Jianpi Qinghua Huanyu Formula in the treatment of gastric precancerous lesions （PLGC） based on network pharmacology combined with gene expression database （GEO） chip analysis and molecular docking technology， and to predict its potential mechanism.,Methods,2,The TCMSP and HERB database was used to collect the effective components and targets of 14 drugs in Jianpi Qinghua Huayu Formula. Differentially expressed genes were obtained through the GSE55696 gene chip in the GEO database. Relevant disease targets of PLGC were obtained by using the DisGeNet， OMIM， and GeneCards disease databases， and the R software was used to obtain the major targets of the treatment of PLGC by Jianpi Qinghua Huayu Decoction. GO and KEGG enrichment analysis of major targets are carried out through R language， and PPI networks of major targets were plotted by STRING database and Cytoscape to screen out core targets， and "effective components - major targets" network of Jianpi Qinghua Huayu Decoction and PLGC were constructed by using Cytoscape to screen out core ingredients components， and finally connect core components with core targets to explore the affinity between proteins and molecules.,Results,2,A total of 226 effective components of Jianpi Qinghua Huayu Decoction were obtained， corresponding to 416 drug targets. 1673 differentially expressed PLGC genes were obtained， and 1302 related targets were obtained in the disease database， so does 149 intersection genes for drugs and diseases. 2802 items were gained by GO enrichment analysis， and 161 related pathways were obtained through KEGG pathway enrichment analysis， mainly involving AGE-RAGE signaling pathway in diabetic complications and cancer-related signaling pathways. The core effective component quercetin， luteolin， etc. were screened， so do core targets TP53， JUN， AKT1， etc. . Molecular docking technology was used to confirm that there was positive binding activity between core components and core targets.,Conclusion,2,Jianpi Qinghua Huayu Formula may act on multiple components and targets by participating in multiple signal pathways， thus playing the role of treating PLGC.
关键词
健脾清化化瘀汤胃癌前病变网络药理学基因表达数据库分子对接药效机制
Keywords
Jianpi Qinghua Huayu Formulaprecancerous lesions of gastric cancernetwork pharmacologyGEO Chipmolecular dockingpharmacodynamic mechanism
references
SUNG H,FERLAY J,SIEGEL RL,et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
QIU HB,CAO SM,XU RH.Cancer incidence,mortality,and burden in China:a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020[J].Cancer Commun(Lond),2021,41(10):1037-1048.
国家消化系疾病临床医学研究中心(上海),国家消化道早癌防治中心联盟,中华医学会消化病学分会幽门螺杆菌学组,等.中国胃黏膜癌前状态和癌前病变的处理策略专家共识(2020年)[J].中华消化杂志,2020,40(11):731-741.
李一桐.健脾清化化瘀汤对HP相关PLGC大鼠胃黏膜miR-21及其靶基因PTEN表达的影响[D].北京:北京中医药大学,2021.
RU J,LI P,WANG J,et al.TCMSP:a database of systems pharmacology for drug discovery from herbal medicines[J].J Cheminform, 2014,6:13.
FANG S,DONG L,LIU L,et al.HERB:a high-throughput experiment-and reference-guided database of traditional Chinese medicine[J].Nucleic Acids Res,2021,49(D1):D1197-D1206.
PIñERO J,RAMíREZ-ANGUITA JM,SAÜCH-PITARCH J,et al.The DisGeNET knowledge platform for disease genomics:2019 update[J].Nucleic Acids Res,2020,48(D1):845-855.
STELZER G,ROSEN N,PLASCHKES I,et al.The genecards suite:from gene data mining to disease genome sequence analyses[J].Curr Protoc Bioinformatics,2016,54:1.30.1-1.30.33.
ZHOU Y,ZHANG Y,LIAN X,et al.Therapeutic target database update 2022:facilitating drug discovery with enriched comparative data of targeted agents[J].Nucleic Acids Res,2022,50(D1):1398-1407.
SZKLARCZYK D,GABLE AL,NASTOU KC,et al.The STRING database in 2021:Customizable protein-protein networks,and functional characterization ofuser-uploaded gene/measurement sets[J].Nucleic Acids Res,2021,49(D1):605-612.
张杨,任静,赵悦,等.中医辨证论治胃癌前病变临床研究进展[J].国际中医中药杂志,2022,44(2):229-232.
徐楚楚,苏晓兰,潘雨烟,等.基于网络药理学的白花蛇舌草-半枝莲药对治疗胃癌前病变作用机制研究[J].北京中医药,2021,40(8):901-906.
董礼刚,张会存,姬莉,等.健脾清化汤对甲硝唑耐药幽门螺杆菌体外生长及菌体内甲硝唑积聚影响研究[J].北京中医药,2021,40(4):374-377.
刘颖初,汪红兵,李乾构.基于数据挖掘总结李乾构治疗慢性萎缩性胃炎用药规律[J].北京中医药,2022,41(5):562-566.
蔡甜甜,林琳,潘华峰,等.三七总皂苷激活JNK信号通路对胃癌前病变大鼠胃黏膜组织的保护作用[J].中华中医药杂志,2019,34(12):5877-5880.
岑丽航,肖瑞琳,李苗,等.蒲公英的抗癌抗炎机制研究进展[J].国际药学研究杂志,2020,47(11):954-961.
王信,马传江,杨培民,等.白花蛇舌草抗炎、抗肿瘤作用研究进展[J].中国现代应用药学,2020,37(19):2420-2426,后插1.
宋瑶.基于iNOS研究健脾清化化瘀汤治疗Hp相关性CAG伴异型增生的作用机制[D].北京:北京中医药大学,2021.
RAUF A,IMRAN M,KHAN IA,et al.Anticancer potential of quercetin:A comprehensive review[J].Phytother Res,2018,32(11):2109-2130.
LAN H,HONG W,FAN P,et al.Quercetin inhibits cell migration and invasion in human osteosarcoma cells[J].Cell Physiol Biochem,2017,43(2):553-567.
SHEN X,SI Y,WANG Z,et al.Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K/Akt signaling[J].Int J Mol Med,2016,38(2):619-626.
IMRAN M,RAUF A,ABU-IZNEID T,et al.Corrigendum to“Luteolin,a flavonoid,as an anticancer agent:A review”[Biomed.Pharmacother.112(2019)108612][J].Biomed Pharmacother,2019,116:109084.
LU J,LI G,HE K,et al.Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer[J].J Transl Med,2015,13:42.
SAYEED MSBIN,AMEEN SS.Beta-sitosterol:a promising but orphan nutraceutical to fight against cancer[J].Nutr Cancer,2015,67(8):1214-1220.
MOON DO,KIM MO,CHOI YH,et al.beta-Sitosterol induces G2/M arrest,endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways[J].Cancer Lett,2008,264(2):181-191.
KIM TW,LEE SY,KIM M,et al.Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells[J].Cell Death Dis,2018,9(9):875.
KALOGERIS T,BAO Y,KORTHUIS RJ.Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning[J].Redox Biol,2014,2:702-714.
CHEN YH,CHEN ZW,LI HM,et al.AGE/RAGE-Induced EMP Release via the NOX-Derived ROS Pathway[J].J Diabetes Res,2018:6823058.
WANG D,FAN Z,LIU F,et al.Hsa-miR-21 and Hsa-miR-29 in tissue as potential diagnostic and prognostic biomarkers for gastric cancer[J].Cell Physiol Biochem,2015,37(4):1454-1462.
HWANG J,MIN BH,JANG J,et al.MicroRNA expression profiles in gastric carcinogenesis[J].Sci Rep,2018,8(1):14393.
LIU J,LIU J,TONG X,et al.Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of huai hua san against ulcerative colitis[J].Drug Des Devel Ther,2021,15:3255-3276.
0
浏览量
0
下载量
0
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备18046208号-2
京公网安备 11010102006710号 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies